Ju Wang
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Fibroblast Growth Factor Research 3
- DNA and Nucleic Acid Chemistry 3
- Studies on Chitinases and Chitosanases 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Co-authors
- An Hong (5 shared papers)Changhong Liu (3 shared papers)Lei Zheng (1 shared paper)Ling Yan (1 shared paper)Lei Wang (1 shared paper)Jinsong Ren (2 shared papers)Qiang Jin Wu (1 shared paper)Ling Zhang (1 shared paper)
- Journals
- Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (1 paper)Nanoscale (1 paper)Molecular Cancer Therapeutics (1 paper)European Journal of Pharmacology (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Ju Wang
24 papers receiving 571 citations
Peers
Comparison fields: 5 of 68
- Drug Discovery 2
- Cancer Research 72
- Biomaterials 53
- Molecular Biology 265
- Pharmaceutical Science 22
Countries citing papers authored by Ju Wang
This map shows the geographic impact of Ju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Wang more than expected).
Fields of papers citing papers by Ju Wang
This network shows the impact of papers produced by Ju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Wang. The network helps show where Ju Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 156 | |
| 2 | 2009 | 101 | |
| 3 | 2005 | 74 | |
| 4 | 2012 | 40 | |
| 5 | 2019 | 34 | |
| 6 | 2012 | 27 | |
| 7 | 2012 | 27 | |
| 8 | 2013 | 23 | |
| 9 | 2011 | 22 | |
| 10 | 2018 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2005 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2012 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2011 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2015 | 3 |
About Ju Wang
Ju Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmaceutical Science, Immunology and Biomaterials, having authored 25 papers that have together received 602 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Fibroblast Growth Factor Research (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Studies on Chitinases and Chitosanases (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Advanced Drug Delivery Systems (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Drug Discovery (2 citations), Cancer Research (72 citations), Biomaterials (53 citations), Molecular Biology (265 citations) and Pharmaceutical Science (22 citations). Ju Wang has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include An Hong, Changhong Liu, Lei Zheng, Ling Yan, Lei Wang, Jinsong Ren, Qiang Jin Wu, Ling Zhang, Ling Zhang and Qiuhui Pan. Their work appears in journals such as Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology, Nanoscale, Molecular Cancer Therapeutics, European Journal of Pharmacology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.